Companies: 10,795·Total market cap: $144.5T

Noxopharm Limited

Noxopharm Limited

NOXOFOTCHealthcare

$0.05

+$0.00(+0.00%)

Market Cap$14781601

P/E Ratio—

52W High$0.045

52W Low$0.045

Avg Volume1K

Open$0.05

Beta0.14

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Noxopharm Limited（NOXOF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NOXOF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.04Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$5.4MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding292.3MShares outstanding history

Next EarningsTBAEarnings history

探索 Noxopharm Limited 数据

分析师预测—

股息不分红

营收$2.4M-60.06%

盈利EPS $-0.01+76.31%

财务快照

FY 2024Revenue$2.4M▼ 60.06% YoY

202220232024

FY 2024Net Income-$3.6M▲ +76.24% YoY

202220232024

FY 2024EPS$-0.01▲ +76.31% YoY

202220232024

TTM:Revenue: $5.4MNet Income: -$11.1MEPS: $-0.04View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Noxopharm Limited

$0.05+0.00%$14.8M #2

American Hemp Ventures, Inc.

$0.98+0.00%$16.5M #3

$0.17-13.04%$13.3M #4

Eiger BioPharmaceuticals, Inc.

$8.50+6.25%$12.6M #5

Nurosene Health Inc.

$0.33-8.71%$14.3M #6

Lifeist Wellness Inc.

$0.04-3.64%$15.8M

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y-46.43%

关于 Noxopharm Limited

CEOGisela Mautner

IPO DateJan 29, 2020

Employees—

CountryAU

Websitenoxopharm.com

Noxopharm Limited a pharmaceutical company, is focused on developing therapeutic solutions for a range of solid tumor cancers and septic shock, catering to both Australian and international markets. …

Biotechnology HealthcareOTCAU

关于股票概览与关键数据

Noxopharm Limited（NOXOF）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 29, 2020 在 OTC 上市。截至最近交易日，NOXOF 股价为 $0.04，市值约为 $14.8M。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2024 财年 Noxopharm Limited 营收 $2.4M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Noxopharm Limited（NOXOF）股价为 $0.04，在 OTC 上市，52周区间为 $0.04 – $0.04。

NOXOF 最新股价NOXOF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议